...is going after the adaptor molecule ASC. ZyVersa licensed an anti-ASC mAb, IC 100, from InflamaCORE LLC...

...preclinical testing for multiple sclerosis. In a 2018 paper published in Frontiers in Neurology , InflamaCore LLC...
...CARD domain containing Chris Lieu, Staff Writer Variant Pharmaceuticals Inc. PYD and CARD domain containing (PYCARD) (ASC) Multiple sclerosis (MS) InflamaCore LLC...